# Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

> **NCT06125782** · PHASE2 · COMPLETED · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 64 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Omega 3 fatty acid
- **DRUG:** Placebo of Omega-3 fatty acid softgel capsule

## Key facts

- **NCT ID:** NCT06125782
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-19
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-02-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125782, "Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06125782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*